What it’s for
- Treatment of hypertension and selected heart-failure cases
A prescription angiotensin-receptor blocker.
Purpose, evidence and practical considerations.
Its established role is in defined cardiovascular conditions. Effects on blood pressure do not demonstrate general brain protection or longer life in low-risk people.
Confidence: strong
The US label carries a boxed warning for fetal toxicity. Risks include hypotension, increased potassium and kidney-function changes; monitoring and medication-interaction review are important, especially with other renin-angiotensin drugs, potassium products, NSAIDs or lithium.
Candesartan blocks angiotensin II at AT1 receptors after conversion from its prodrug, reducing vasoconstriction and aldosterone effects. This lowers blood pressure and alters cardiac and renal haemodynamics.
Regulatory status: FDA-approved prescription medicine for hypertension and selected heart-failure indications
The evidence on this page does not automatically apply to:
How people use it, with their schedules, context and original sources.
8 mg · Daily
blood pressure, heart, kidney; 'possibly... brain inflammation'
Dose and schedule patterns reported in public protocols; these are observations, not prescribing advice. Private and hidden usage is excluded.
daily
These share a protocol with this intervention. This does not establish that they work together or are suitable alternatives.